Filters
Phase
Intervention Type
Status
Location:
LocationClose
Distance
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Need to find the closest trial?
Sort By Distance
Save trials for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
3 clinical trials found
iStent Infinite and iDose TR for Management of Moderate to Severe Primary Open Angle Glaucoma Are a Safe and Effective Alternative to Filtering Surgery for IOP Reduction in Patients With Medically Uncontrolled Glaucoma. (POAG)
Enrollment Status: Recruiting
Publish Date: November 14, 2025
Intervention Type: Device, Drug
Study Phase: Phase 4
Summary: The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Enrollment Status: Recruiting
Publish Date: July 22, 2025
Intervention Type: Drug, Other, Procedure
Study Phase: Phase 2/Phase 3
Summary: Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intracameral Implant) in Conjunction With Cataract Surgery vs. Cataract Surgery Alone
Enrollment Status: Recruiting
Publish Date: February 27, 2025
Intervention Type: Combination product, Procedure
Study Phase: Phase 4
Summary: This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Showing 1-3 of 3
Last Updated: 01/07/2026